E11.3399 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye

Name of the Condition

• Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye

Summary

Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye, is a condition where chronic high blood sugar levels cause damage to the small blood vessels in the retina, leading to moderate retinal changes without swelling in the macula. This stage is characterized by increased microaneurysms, dot-blot hemorrhages, hard exudates, and venous beading, but no significant macular edema. While vision may not be immediately affected, ongoing monitoring is essential to prevent progression to more severe stages.

Causes

High blood sugar levels over time damage the retinal blood vessels, leading to moderate nonproliferative diabetic retinopathy. Insulin resistance or insufficient insulin production in type 2 diabetes contributes to sustained hyperglycemia, which triggers vascular changes in the retina. Metabolic factors associated with diabetes, such as advanced glycation end products, also play a role in this ocular complication.

Risk Factors

• Poorly controlled blood glucose levels.
• Long duration of diabetes.
• Hypertension and dyslipidemia.
• Smoking.
• Obesity and sedentary lifestyle.

Symptoms

• Mild to moderate blurring or fluctuating vision.
• Presence of floaters or spots in the visual field.
• Difficulty with night vision.

Diagnosis

Diagnosis involves a comprehensive eye examination, including dilated retinal imaging (e.g., fundus photography or optical coherence tomography) to assess retinal changes. Blood tests to evaluate glycemic control and other metabolic markers may also be performed. The absence of macular edema is confirmed through imaging and clinical evaluation.

Treatment Options

• Tight glycemic control through medication, diet, and exercise.
• Blood pressure and lipid management.
• Regular eye examinations to monitor progression.
• Laser photocoagulation or anti-VEGF therapy if retinopathy advances.

Prognosis and Follow-Up

With proper management, progression to severe retinopathy can be slowed. Regular follow-up appointments (every 6–12 months) are recommended to monitor retinal changes and adjust treatment as needed. Early intervention improves long-term visual outcomes.

Complications

• Progression to severe nonproliferative or proliferative diabetic retinopathy.
• Macular edema (if not previously present).
• Vision loss or blindness if untreated.

Lifestyle & Prevention

• Maintain stable blood glucose levels.
• Adopt a healthy diet and regular physical activity.
• Avoid smoking and limit alcohol intake.
• Manage blood pressure and cholesterol.

When to Seek Professional Help

Seek immediate care if you experience sudden vision changes, increased floaters, or eye pain, as these may indicate worsening retinopathy or other complications.

Tips for Medical Coders

Document the eye laterality (unspecified) and confirm the absence of macular edema. Ensure clinical notes support the moderate nonproliferative stage and type 2 diabetes diagnosis. Use this code when the eye affected is not specified and macular edema is absent.